معرفی
Stephen Kirnon serves as Visiting Faculty and Program Director for the Social Entrepreneurship and Change (SEC) Program within the Education Division of Pepperdine University's Graduate School of Education and Psychology. With over 30 years of executive leadership in biomedical and medical device industries—including roles as CEO of Shawshank Therapeutics, PharmaPlan LLC, and Vitavis Laboratories (acquired by Nestle Health Sciences in 2017)—he integrates real-world business innovation into academic curriculum development.
His educational credentials include:
- EdD in Organization Change and Transformational Leadership from Pepperdine University
- MBA from Pepperdine University
- BA in Biochemistry from Harvard University
Dr. Kirnon's expertise centers on embedding social entrepreneurship within for-profit business models, emphasizing transformational leadership and organizational change. His industry background in pharmaceuticals (e.g., Pepgen Corporation, Target Protein Technologies) and medical devices (e.g., commercialization of GlucoWatch® at Cygnus, Inc.) informs interdisciplinary approaches to solving societal challenges through business innovation.
As SEC Program Chair, he shapes curriculum and academic strategy while maintaining active industry engagement through board positions. His work bridges corporate leadership with social impact initiatives, reflecting his philosophy that profit-driven enterprises must inherently address societal needs.
